Featured Articles

• Less Chaos, More Capacity: Tools Physios Are Leaning On in 2026 10-02-2026

  With no shortage of digital tools available, the challenge for many physios is knowing which ones actually help. This article explores how clinics are using technology more intentionally to protect clinical time, reduce friction and create real capac

  READ MORE
• What's Changing in Physio Research -- and Why It Matters to Your Practice 10-02-2026

  Physio research is evolving — not just in volume, but in focus. This article explores how shifts towards context, load tolerance and behaviour change are influencing clinical reasoning and everyday practice. Physiotherapy research has never

  READ MORE
• Medical biotech Ferronova completes enrolment for gastric and oesophageal cancer image-guided surger 10-02-2026

  ADELAIDE, Australia, Feb. 10, 2026 /PRNewswire/ -- Australian company Ferronova announced today it has completed enrolment of patients for its two-year trial to progress commercialisation of FerroTrace, a novel nanoparticle image-guided surgery solut

  READ MORE
• MerryLife Biomedical Reports Positive Phase 1 Results and Plans for Global Phase 2 Trial for TML-6, 10-02-2026

  TAINAN, Feb. 10, 2026 /PRNewswire/ -- MerryLife Biomedical Inc., a clinical-stage biotechnology company focused on neurodegenerative diseases, today announced positive Phase 1 results for TML-6, its investigational oral therapy for Alzheimer's di

  READ MORE
• Not a real doctor: AI struggles to treat human patients 10-02-2026

  Just because artificially intelligent chatbots can pass medical exams does not mean they should operate as doctors, a study warns, as they can provide deadly medical advice. In one case, two men who asked an AI tool about a brain bleed received op

  READ MORE
• LT3001 DEMONSTRATES FUNCTIONAL IMPROVEMENTS IN PATIENTS WITH DISABLING ACUTE ISCHEMIC STROKE 08-02-2026

  TAIPEI, Feb. 7, 2026 /PRNewswire/ -- Lumosa Therapeutics (Lumosa; 6535.TWO) today announced positive results from two independent Phase 2 clinical trials with its novel stroke drug LT3001 (Odatroltide). LT3001 is a first-in-class dual-functional ther

  READ MORE
• Mum turns child's diagnosis into pledge to help 08-02-2026

  When mother to two healthy daughters Sami Glastonbury went for a routine scan during her third pregnancy, she felt confident and curious - but like it was just a formality. Instead, she watched the radiographer's expression change.[subscribe]

  READ MORE
• Medical workers 'robbed' child of chance at survival 06-02-2026

  Hospital staff and paramedics "robbed" a 15-year-old boy of his best chance at survival by failing to intervene earlier after he suffered an allergic reaction, his grieving parents say. Melbourne teen Max McKenzie died in August 2021 aft

  READ MORE
• Major study debunks cholesterol drug side-effect fears 06-02-2026

  Millions of Australians using drugs to combat bad cholesterol can rest easier after scientists dispelled common concerns over side effects. Despite being highly effective at reducing low-density lipoprotein cholesterol, statins have long been blam

  READ MORE
• Providence Therapeutics Announces World-First Personalized Pediatric mRNA Cancer Vaccine Trial 05-02-2026

  Landmark Australian study opens new possibilities for children with aggressive brain tumors and signals opportunity for Canada and USA. CALGARY, AB and BRISBANE, Australia , Feb. 5, 2026 /PRNewswire/ -- Providence Therapeutics, a Canadian clinical

  READ MORE